Stealth BioTherapeutics Company Profile

23:46 EDT 23rd June 2018 | BioPortfolio

Stealth BioTherapeutics is a privately-held biopharmaceutical company committed to bringing mitochondria-targeted therapeutics to patients to treat both common and rare diseases. As the key common element in a variety of serious, debilitating diseases, mitochondria - the cell’s energy source - offer a promising yet untapped therapeutic target for diseases with significant unmet treatment needs. Stealth is developing its lead compounds Bendavia™ and Ocuvia™ in multiple therapeutic areas, including cardio-renal diseases, ophthalmic disorders and orphan mitochondrial diseases, and defining the broad potential of mitochondria-targeted therapies. Stealth’s promising pipeline of preclinical and clinical compounds is supported by more than 100 independent, peer-reviewed publications, abstracts and presentations.

News Articles [236 Associated News Articles listed on BioPortfolio]

Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Leber’s Hereditary Optic Neuropathy

BOSTON – December 18, 2017 – Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S....

Stealth Bio Raises $100 Million from China Investors for Mitochondrial Candidates

Stealth Biotherapeutics, a Boston a clinical-stage biopharma that targets mitochondrial dysfunction, completed a $100 million financing in two convertible note rounds led by Nan Fung Technology's Pivo...

Note rounds nab $100M for Stealth

Stealth BioTherapeutics intends to use the $100 million raised from two convertible note rounds to launch a Phase IIb study o -More- 

Orphan status granted to Stealth's Barth syndrome therapy

The FDA gave orphan status to Stealth BioTherapeutics' elamipretide, which is being developed to treat patients with Barth sy -More- 

#jobs #lifescience Stealth Biotech: Chief Scientific Officer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Stealth Biotech: Chief Scientific Officer . Competitive: Stealth Biotech: Our...

Is China's J-20 Stealth Fighter Really 'Operational?'

The Chinese People’s Liberation Army Air Force (PLAAF) has declared its Chengdu J-20 fifth-generation stealth fighter operational. With the J-20 formally attaining initial operational capability, C...

Pre-Market Technical Scan on Biotech Equities -- Eleven Biotherapeutics, Endocyte, Esperion ... Eleven Biotherapeutics On Wednesday, shares in Cambridge, Massachusetts-based Eleven Biotherapeutics Inc. recorded a trading volume of 1.09 million shares, whic...

Is the FAA Endangering America's Stealth Fighters?

Hence the Federal Aviation Administration (FAA) has come up with a plan that requires aircraft to broadcast their positions to avoid mid-air collisions. Or more specifically, what if they are militar...

Drugs and Medications [14 Associated Drugs and Medications listed on BioPortfolio]


Plasma Protein Fraction (Human) 5%, USPPlasmanate®


Immune Globulin (Human)GamaSTAN™ S/DSolvent/Detergent Treated


Albumin (Human) 5%, USPPlasbumin ®-5


Albumin (Human) 5%, USPPlasbumin ®-5


Albumin (Human) 20%, USPPlasbumin®-20

PubMed Articles [42 Associated PubMed Articles listed on BioPortfolio]

Toward best practices in data processing and analysis for intact biotherapeutics by MS in quantitative bioanalysis.

Typically, quantitation of biotherapeutics from biological matrices by LC-MS is based on a surrogate peptide approach to determine molecule concentration. Recent efforts have focused on quantitation o...

Intrabilayer 64Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes.

Doxorubicin (Dox)-loaded stealth liposomes (similar to those in clinical use) can incorporate small amounts of porphyrin-phospholipid (PoP), to enable chemophototherapy (CPT). PoP is also an intrinsic...

Integrated BioTherapeutics.

Glycosimilarity assessment of biotherapeutics 1: Quantitative comparison of the N-glycosylation of the innovator and a biosimilar version of etanercept.

The carbohydrate moieties on the polypeptide chains in most glycoprotein based biotherapeutics and their biosimilars play essential roles in such major mechanisms of actions as antibody-dependent cell...

Social movement involvement and healthy diet and activity behaviors among US adults.

Unhealthy lifestyle behaviors, namely poor diet and inadequate physical activity, significantly contribute to poor health and obesity risk, which in turn impact chronic illness outcomes. A possible ap...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study

This is a Phase 2, randomized, double-blind, placebo-controlled crossover study which will enroll up to 36 subjects (anticipated) with genetically confirmed mitochondrial disease who have ...

Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

To provide Stealth liposomal doxorubicin hydrochloride ( DOX-SL ) as a therapy for Kaposi's sarcoma patients who have no remaining treatment options other than DOX-SL or patients who have ...

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

To determine the efficacy of Stealth liposomal doxorubicin hydrochloride (DOX-SL) in the treatment of moderate to severe AIDS-related Kaposi's sarcoma (KS) by comparison with the establish...

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

In this study, PLD, an anthracycline encapsulated in stealth liposomes, which are believed to efficiently deliver the doxorubicin within the tumour mass with less toxicity compared with st...

A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

To evaluate the safety and effectiveness of Stealth liposomal doxorubicin hydrochloride (DOX-SL) in the long-term treatment of AIDS-related Kaposi's sarcoma (KS) in patients who previously...

Companies [105 Associated Companies listed on BioPortfolio]

Stealth BioTherapeutics

Stealth BioTherapeutics is a privately-held biopharmaceutical company committed to bringing mitochondria-targeted therapeutics to patients to treat both common and rare diseases. ...

Stealth Therapeutics Inc.

Stealth Therapeutics was founded in 2006 for the purpose of designing and developing a portfolio of improved venous access devices. The technology is derived from the clinical pra...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

Project Stealth

Napro Biotherapeutics Incorporated

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent ...

More Information about "Stealth BioTherapeutics" on BioPortfolio

We have published hundreds of Stealth BioTherapeutics news stories on BioPortfolio along with dozens of Stealth BioTherapeutics Clinical Trials and PubMed Articles about Stealth BioTherapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stealth BioTherapeutics Companies in our database. You can also find out about relevant Stealth BioTherapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Corporate Database Quicklinks

Searches Linking to this Company Record